<DOC>
	<DOCNO>NCT00216619</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness ( beyond 6 month ) individualize dos ( 100 200 milligram ) topiramate prevention migraine headache period 26 week .</brief_summary>
	<brief_title>The Prolonged Use Topiramate Preventing Migraine Headaches</brief_title>
	<detailed_description>Previous study show topiramate effective prevent migraine headache . This study start 4-week baseline period treatment give , follow 26-week period patient 's dose adjust keep stable 4 week . The dose start 25 milligram topiramate per day increase 25 milligram per day weekly raise either target -- 100 milligram per day -- maximum dose well tolerate 200 milligram per day . Patients randomize receive topiramate remain dose . The comparison phase study 26-week period change migraine day patient topiramate ( take least 50 milligram per day ) compare change migraine day patient placebo . Also study patient ' health-related quality life assess questionnaire fill specific visit well patient ' view safety tolerability topiramate . The study hypothesis number migraine day , period , attack last 4 week double-blind phase , relative last 4 week open-label phase , reduced topiramate group placebo group . During open-label ( 26-weeks ) double-blind phase ( 26-weeks ) , patient receive topiramate take 25 milligram 100 milligram daily mouth ; increase 25 milligram per day weekly ; dose exceed 200 milligram per day must stable last 4 week .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Established history migraine least one year ; Migraine meet HIS ( International Headache Society ) criteria An average least 4 monthly migraine day 3 month precede trial entry Capable keep trial record ; Patient use migraine prophylactic medication month prior trial entry ( flunarizine : 3 month prior entry ) Patient fail ( lack efficacy ) two adequate previous regimen migraine prophylactic medication Patient history severe drug allergy hypersensitivity Patient overuse analgesic , opiate , ergot and/or triptans Patient use topiramate regularly</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>chronic migraine</keyword>
	<keyword>Topiramate</keyword>
	<keyword>migraine</keyword>
	<keyword>headache</keyword>
	<keyword>chronic headache</keyword>
</DOC>